| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $6,346,067 | +18,388 | +21% | $345.12 | 105,587 | 10 Feb 2023 | Direct | |
| holding | LLY | Common Stock | 70,000 | 10 Feb 2023 | By Trust | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +9,941 | $0.000000 | 9,941 | 10 Feb 2023 | Common Stock | 9,941 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |